Whitebox Advisors’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Hold
152,500
﹤0.01% 406
2026
Q1
$18.3K Hold
152,500
﹤0.01% 509
2025
Q4
$47.3K Hold
152,500
﹤0.01% 392
2025
Q3
$44.2K Hold
152,500
﹤0.01% 338
2025
Q2
$38.2K Hold
152,500
﹤0.01% 311
2025
Q1
$30.5K Buy
+152,500
New +$26.8K ﹤0.01% 243

Other funds holding TDACW

Whitebox Advisors's TDACW Position: Q2 2026 in Review

Whitebox Advisors held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q2 2026 at 152,500 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #406.

Whitebox Advisors first reported a position in TDACW in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

  • Whitebox Advisors held 152,500 shares of Translational Development Acquisition Corp Warrants worth $217K as of Q2 2026.
  • Whitebox Advisors left its Translational Development Acquisition Corp Warrants share count unchanged in Q2 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of Whitebox Advisors's portfolio in Q2 2026, its #406 holding.
  • Whitebox Advisors first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 6 quarters since.
  • 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on Whitebox Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.